Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis
This study is currently recruiting participants.
Verified January 2013 by University Hospital, Ghent
Sponsor:
University Hospital, Ghent
Information provided by (Responsible Party):
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00221572
First received: September 12, 2005
Last updated: January 29, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.
| Condition | Intervention |
|---|---|
|
Cystic Fibrosis |
Procedure: Determination of bot density of Cystic Fibrosis patients |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Can Quantitative Ultrasound be Used for the Evaluation of Bone Health in Adolescents and Adults With Cystic Fibrosis |
Resource links provided by NLM:
Genetics Home Reference related topics:
cystic fibrosis
MedlinePlus related topics:
Cystic Fibrosis
U.S. FDA Resources
Further study details as provided by University Hospital, Ghent:
| Estimated Enrollment: | 100 |
| Study Start Date: | July 2005 |
| Estimated Study Completion Date: | July 2013 |
| Estimated Primary Completion Date: | July 2013 (Final data collection date for primary outcome measure) |
Intervention Details:
Detailed Description:
-
Procedure: Determination of bot density of Cystic Fibrosis patients
Determination of bot density of Cystic Fibrosis patients.
Measurement of bone density of Cystic Fibrosis patients with two techniques and correlation to serum bone parameters, use of steroids, lung function and nutritional status.
Eligibility| Ages Eligible for Study: | 12 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients with Cystic Fibrosis
Criteria
Inclusion Criteria:
- Patients with Cystic Fibrosis
Exclusion Criteria:
-
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00221572
Contacts
| Contact: Eddy Robberecht, MD, PhD | + 32 9 332.35.89 | eddy.robberecht@UGent.be |
Locations
| Belgium | |
| University Hospital Ghent | Recruiting |
| Ghent, Belgium, 9000 | |
| Contact: Stephanie Van Biervliet, MD + 32 9 332.55.14 stephanie.vanbiervliet@UGent.be | |
Sponsors and Collaborators
University Hospital, Ghent
Investigators
| Principal Investigator: | Stephanie Van Biervliet, MD | University Hospital, Ghent |
More Information
Additional Information:
No publications provided
| Responsible Party: | University Hospital, Ghent |
| ClinicalTrials.gov Identifier: | NCT00221572 History of Changes |
| Other Study ID Numbers: | 2005/149 |
| Study First Received: | September 12, 2005 |
| Last Updated: | January 29, 2013 |
| Health Authority: | Belgium: Institutional Review Board |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 22, 2013